Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Molecular Cancer Research : MCR|November 24, 2020
Characterization of Clonal Evolution in Microsatellite Unstable Metastatic Cancers through Multiregional Tumor SequencingRussell Bonneville, Anoosha Paruchuri, Michele R Wing, et al.
Oncotarget|February 6, 2019
Genomic characterization of metastatic ultra-hypermutated interdigitating dendritic cell sarcoma through rapid research autopsyHui-Zi Chen, Russell Bonneville, Lianbo Yu, et al.
Prostate Cancer and Prostatic Diseases|May 3, 2019
Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancerMelanie A Krook, Hannah Barker, Hui-Zi Chen, et al.
NPJ Precision Oncology|September 17, 2024
FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancerLeah Stein, Karthikeyan Murugesan, Julie W Reeser, et al.
Molecular Cancer Therapeutics|January 9, 2020
Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion CholangiocarcinomaMelanie A Krook, Alexandria Lenyo, Max Wilberding, et al.
Cold Spring Harbor Molecular Case Studies|August 3, 2019
Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsyMelanie A Krook, Russell Bonneville, Hui-Zi Chen, et al.
JTO Clinical and Research Reports|September 30, 2021
Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research AutopsyHui-Zi Chen, Russell Bonneville, Anoosha Paruchuri, et al.
The Journal of Molecular Diagnostics : JMD|August 14, 2017
Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid TumorsJulie W Reeser, Dorrelyn Martin, Jharna Miya, et al.
JCO Precision Oncology|January 9, 2023
Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural VariationsEmily L Hoskins, Eric Samorodnitsky, Michele R Wing, et al.
NPJ Precision Oncology|July 3, 2025
Prevalence and biological impact of clinically relevant gene fusions in head and neck cancersEmily L Hoskins, Raven Vella, Julie W Reeser, et al.
Pageof 2